Plus: Preeclampsia predictors show limitations, benefits of streamlined aneuploidy assays, and LiSWT research needs.
Future Fertility's $4.1M Series A — led by M Ventures and Whitecap Venture Partners — scales AI-driven egg quality assessment globally, impacting embryologists. Meanwhile, Plan Your Baby, a UK virtual fertility clinic employing a telehealth model, closed a seed round, streamlining IVF access for patients. These developments highlight ongoing innovation in fertility care delivery and diagnostic technologies for clinical practice. Five takes inside, plus a quick-hits roundup.
Future Fertility, an AI platform for objective egg quality assessment, secured $4.1 million in a Series A funding round. M Ventures and Whitecap Venture Partners led the round, with participation from Sandpiper Ventures, Gaingels, and Jolt VC. This follows a seed round raised in 2022.
Read the full story →Plan Your Baby, a UK-based virtual fertility clinic offering IVF and fertility treatments via telehealth, has closed a seed round from strategic angel investors. 85% of the IVF process occurs near patients through over 450 UK partner locations. Financial terms were not disclosed.
Read the full story →New research indicates that SFlt-1 and PlGF are limited in predicting adverse maternal events in women with preeclampsia. This study contributes to the understanding of maternal health and pregnancy care outcomes.
Read the full story →Formal postpartum care guidelines for LiSWT require randomized controlled trials with adequate sample sizes, defined treatment parameters, long-term follow-up, and dedicated safety data in lactating patients. Cost-effectiveness analysis is also a priority research direction.
Read the full story →Ramu Perni, MD, MBA, highlights the benefits of a streamlined aneuploidy assay in obstetric care. This "one tube" workflow streamlines obstetric practices by enabling add-on RBC and platelet antigen tests.
Read the full story →